Sanofi’s diabetes drug Soliqua launched in India
A once-daily solution that breaks through the complexity of living with type 2 diabetes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
glycemic control
Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil
Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes
Zydus gets USFDA nod for ZITUVIMET to treat adults with type 2 diabetes
ZITUVIMET contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride, a…
Glenmark Pharma launches triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India
Zita DM helps improve glycemic control in adult patients with high HbA1c and/or other co-morbidities, those patients whose…
Sanofi gets marketing approval for its diabetes drug Soliqua in India
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes
The FDC will be marketed under two brand names, Remo V and Remozen V, priced at Rs 14 per tab and Rs 28 per day cost of therapy